IL1B and endothelial dysfunction: Its mechanism of action involves preventing the oligomerization of the inflammasome complex, leading to decreased expression of inflammatory cytokines (such as IL-1β and IL-18), as well as reduced renal fibrosis, endothelial dysfunction, and oxidative stress [134].